Literature DB >> 25583620

Antihypertensive therapy in 2014: Linking pathophysiology to antihypertensive treatment.

Gianfranco Parati1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25583620     DOI： 10.1038/nrcardio.2014.221

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Hypertension: Cardiac hypertrophy as a target of antihypertensive therapy.

Authors:  Alberto Zanchetti
Journal:  Nat Rev Cardiol       Date:  2010-02       Impact factor: 32.419

Review 2.  Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

Review 3.  Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk--overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

Review 4.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

5.  Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.

Authors:  Stephan H Schirmer; Marwa M Y A Sayed; Jan-Christian Reil; Christian Ukena; Dominik Linz; Michael Kindermann; Ulrich Laufs; Felix Mahfoud; Michael Böhm
Journal:  J Am Coll Cardiol       Date:  2013-12-04       Impact factor: 24.094

6.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

7.  Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial.

Authors:  Gianfranco Parati; Grzegorz Bilo; Andrea Faini; Barbara Bilo; Miriam Revera; Andrea Giuliano; Carolina Lombardi; Gianluca Caldara; Francesca Gregorini; Katarzyna Styczkiewicz; Antonella Zambon; Alberto Piperno; Pietro Amedeo Modesti; Piergiuseppe Agostoni; Giuseppe Mancia
Journal:  Eur Heart J       Date:  2014-08-26       Impact factor: 29.983

8.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

9.  Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control.

Authors:  Peter Lloyd-Sherlock; John Beard; Nadia Minicuci; Shah Ebrahim; Somnath Chatterji
Journal:  Int J Epidemiol       Date:  2014-02-06       Impact factor: 7.196

10.  Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality.

Authors:  Feng J He; Sonia Pombo-Rodrigues; Graham A Macgregor
Journal:  BMJ Open       Date:  2014-04-14       Impact factor: 2.692
  10 in total
  1 in total

Review 1.  Neuroimmune crosstalk in the pathophysiology of hypertension.

Authors:  Laura Calvillo; Mariela M Gironacci; Lia Crotti; Pier Luigi Meroni; Gianfranco Parati
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.